[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353673-105":59,"doc-detail-353673-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","effects-of-n361-glycosylation-on-epidermal-growth-factor-receptor-biological-function-read-online-free","Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function - read online free","","N361 glycosylation is investigated for its role in regulating epidermal growth factor receptor (EGFR) function in cancer-relevant settings. The study stably expresses a glycosylation-deficient EGFR mutant (N361A) with or without the oncogenic L858R mutation, then evaluates EGFR–HER2 co-localization via proximity ligation assays. N361A increases membrane localization and co-localization, reduces proliferation, impairs binding and response to growth factor ligands, and lowers sensitivity to the EGFR-targeting therapeutic antibody necitumumab, highlighting dominant-negative effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/effects-of-n361-glycosylation-on-epidermal-growth-factor-receptor-biological-function-read-online-free/353673/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/effects-of-n361-glycosylation-on-epidermal-growth-factor-receptor-biological-function-read-online-free/353673.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main biological question about N361 glycosylation and EGFR?","Question",{"text":112,"@type":113},"The study examines how glycosylation at residue N361 influences EGFR biological function, including localization, co-localization with HER2, and downstream proliferation-related behaviors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the N361A glycosylation-deficient mutant affect EGFR and HER2 behavior?",{"text":117,"@type":113},"N361A increases EGFR membrane localization and EGFR–HER2 non-productive co-localization compared with glycosylation-competent conditions.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does loss of N361 glycosylation reduce necitumumab efficacy?",{"text":121,"@type":113},"The mutant EGFR shows reduced sensitivity to inhibition by necitumumab, which binds the extracellular domain, consistent with impaired EGFR function and signaling necessary for therapeutic response.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353673,1790167745,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nEffects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function  \nDennis Lam 1,2, Brandon Arroyo 1,3, Ariel N. Liberchuk 1,4, Jessica Das 1,5, Leonard J. Ash 1,5, Khizr M. Khan 1,2, Jayati Mondal 1,6,7 and Andrew L. Wolfe 1,2,5,8,9, *  \nAcademic Editor: Roberto Benelli  \nReceived: 22 December 2025  \nAccepted: 28 January 2026  \nPublished: 31 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Biological Sciences, Hunter College, City of University of New York, New York, NY 10065, USA  \n2 New York Research and Mentoring for Postbaccalaureates (NY-RaMP) Program, Hunter College, City of University of New York, New York, NY 10021, USA  \n3 Maximizing Access to Research Careers Program, Hunter College, City University of New York, New York, NY 10065, USA  \n4 Macaulay Honors College, Hunter College, City University of New York, New York, NY 10065, USA  \n5 Molecular, Cellular, and Developmental Biology Ph.D. Subprogram, The Graduate Center, City University of New York, New York, NY 10016, USA  \n6 Yalow Scholars Program, Hunter College, City of University of New York, New York, NY 10065, USA  \n7 Damon Runyon Cancer Research Foundation, Scholars Program for Advancing Research and Knowledge, New York, NY 10006, USA  \n8 Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA  \n9 Biochemistry Ph.D. Program, The Graduate Center, City University of New York, New York, NY 10016, USA  \n* Correspondence: [awolfe@genectr.hunter.cuny.edu](awolfe@genectr.hunter.cuny.edu)  \nSimple Summary  \nActivating genetic changes in the gene that encodes epidermal growth factor receptor (EGFR) frequently promote uncontrolled proliferation in lung cancer and breast cancer. Glycosylation modifications added to asparagines after protein translation can impact protein function. This study focuses on the impacts of a site on EGFR that is frequently N-glycosylated. We found that glycosylation-deficient mutation of this site promotes increased membrane localization and non-productive co-localization of EGFR with its binding partner HER2 . Proliferation was reduced in mutant cells. The mutant EGFR was deficient at binding and responding to growth factor ligands that promote cell proliferation. Loss of this glycosylation site reduced the efficacy of the cancer therapeutic antibody necitumumab, which binds nearby. These findings underline the critical relevance of posttranslational glycosylation modifications on EGFR function, cell biology, and responses to therapeutic agents.  \nAbstract  \nBackground: Epidermal growth factor receptor (EGFR) is a transmembrane tyrosine kinase that is frequently post-translationally modified by glycosylation. In cancer, EGFR amplifications and hotspot mutations such as L858R that promote proliferation have been detected in a significant fraction of non-small cell lung carcinomas and breast adenocarcinomas. Analyses of disruptions to glycosylation pathways in cancer cells identified EGFR glycosylation at residue N361 as one of the most heavily impacted sites. Methods: We stably expressed a glycosylation-deficient mutant EGFR, N361A, with or without the oncogenic EGFR mutation L858R in cells. Proximity ligation assays were employed to study the effects of the glycosylation mutant on the co-localization of EGFR and HER2 . The effects of the glycosylation-deficient mutant on the efficacy of agonists, such as EGF andamphiregulin, or antagonists, such as osimertinib and necitumumab, were defined using cell viability assays and immunoblots. Results: N361A increased the membrane localization  \nand co-localization of EGFR with its binding partner HER2 . The glycosylation-deficient mutation decreased cell proliferation, including proliferative responses to EGFR ligands. The mutant cells demonstrated reduced sensitivit","cbCaiuUwoxIsUEDm","https://ap.wps.com/l/cbCaiuUwoxIsUEDm","pdf",2433171,17,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction\n## EGFR signaling and ligand-induced activation\n## EGFR mutations and cancer prevalence\n# Methods\n## Stable expression of EGFR mutants\n## Proximity ligation assays\n## Cell viability assays and immunoblots\n# Results\n## Membrane localization and EGFR–HER2 co-localization\n## Effects on proliferation and ligand responses\n## Reduced necitumumab sensitivity\n# Conclusions","[{\"question\":\"What is the main biological question about N361 glycosylation and EGFR?\",\"answer\":\"The study examines how glycosylation at residue N361 influences EGFR biological function, including localization, co-localization with HER2, and downstream proliferation-related behaviors.\"},{\"question\":\"How does the N361A glycosylation-deficient mutant affect EGFR and HER2 behavior?\",\"answer\":\"N361A increases EGFR membrane localization and EGFR–HER2 non-productive co-localization compared with glycosylation-competent conditions.\"},{\"question\":\"Why does loss of N361 glycosylation reduce necitumumab efficacy?\",\"answer\":\"The mutant EGFR shows reduced sensitivity to inhibition by necitumumab, which binds the extracellular domain, consistent with impaired EGFR function and signaling necessary for therapeutic response.\"}]","Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function - read online free | PDF",1790106685,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7d8bcd8cd1237cdcdfaff702cb321d2.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a97cde151731b97b070c91538538ff4.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2468d681246d673cf3073cdddf8643cc.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53f9c406f73409706b02fe45ab4f892e.webp",980,1385]